Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,092
in 3 filings, $19K under 10b5-1 plans

Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. O'Neill Gilmore Neil −$16K CEO sold 2% of stake
  2. Burkly Linda −$2K EVP, CHIEF SCIENTIFIC OFFICER sold 1% of stake
  3. Parison Amy −$1K SVP, Chief Financial Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-06-12 MULLEN JAMES C Director Grant or award · Stock Option (right to buy) +11,538 11,538
2019-06-12 Vaishnaw Akshay Director Grant or award · Stock Option (right to buy) +11,538 11,538
2019-06-12 Collins Cynthia Interim CEO Grant or award · Stock Option (right to buy) +11,538 11,538
2019-03-18 Myer Vickesh Chief Technology Officer Option exercise +3,000 $0.65 $2K 3,000
2019-03-18 Myer Vickesh Chief Technology Officer Sale −3,000 $24.50 $74K 0
2019-03-18 Myer Vickesh Chief Technology Officer Option exercise · Stock Option (right to buy) −3,000 73,307
2019-03-05 Hopfield Jessica Director Purchase +10,200 $23.94 $244K 16,900
2019-02-20 Myer Vickesh Chief Technology Officer Option exercise +3,000 $0.65 $2K 3,000
2019-02-20 Myer Vickesh Chief Technology Officer Sale −3,000 $20.42 $61K 0
2019-02-20 Myer Vickesh Chief Technology Officer Option exercise · Stock Option (right to buy) −3,000 76,307
2019-02-06 Albright Charles Chief Scientific Officer Grant or award · Stock Option (right to buy) +48,750 48,750
2019-02-06 Albright Charles Chief Scientific Officer Grant or award · Restricted Stock Units +8,125 8,125
2019-02-06 Myer Vickesh Chief Technology Officer Grant or award · Stock Option (right to buy) +48,750 48,750
2019-02-06 Myer Vickesh Chief Technology Officer Grant or award · Restricted Stock Units +8,125 8,125
2019-02-05 Scadden David Director Grant or award · Stock Option (right to buy) +23,076 23,076
2019-02-04 Hack Andrew A. F. Chief Financial Officer Option exercise +6,895 $6.48 $45K 6,895
2019-02-04 Hack Andrew A. F. Chief Financial Officer Sale −6,895 $21.39 $147K 0
2019-02-04 Hack Andrew A. F. Chief Financial Officer Option exercise · Stock Option (right to buy) −6,895 9,618
2019-01-31 Collins Cynthia Director Grant or award · Restricted Stock Units +8,283 8,283
2019-01-31 Myer Vickesh Chief Technology Officer Grant or award · Restricted Stock Units +16,722 16,722

Page 13 of 15 · 283 trades